Logotype for Prophase Labs Inc

Prophase Labs (PRPH) investor relations material

Prophase Labs Status Update summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Prophase Labs Inc
Status Update summary19 Dec, 2025

Overview and Strategic Initiatives

  • Entered a non-binding LOI for a reverse merger with ABL, a profitable European biotech, with ABL to own approximately 76% of the combined entity and a preliminary valuation of up to $30 million for the legacy business.

  • The merger aims to create significant synergies by combining U.S. and European distribution, expertise, and leveraging ABL’s global infrastructure.

  • The deal structure includes both equity and debt financing, with current shareholders retaining some debt and benefiting from future Crown Medical collections.

  • No breakup fees or penalties are included if the transaction is abandoned; each party bears its own costs.

  • Transaction is subject to due diligence, definitive agreements, regulatory approvals, and Nasdaq requirements, with documentation expected within 60 to 90 days.

Value Distribution and Carve-Outs

  • Current shareholders may receive a special cash dividend of up to $10 million, funded by capital raised in the merger.

  • Crown Medical collections, estimated at $50 million net, will be carved out for current shareholders, with litigation against insurance companies for underpaid COVID testing claims progressing and settlements anticipated soon.

  • Combined company to assume only about $5 million of existing indebtedness; other legacy liabilities remain with ProPhase.

Business Verticals and Asset Value

  • The BE-Smart esophageal cancer test targets a $7–14 billion market, with full USPTO patent approval, >95% technical success rate, and ongoing commercialization and validation efforts.

  • Nebula Genomics, with a 16-petabyte DNA dataset, is break-even to profitable, has a new subscription model, and is positioned as a compelling acquisition candidate.

  • DNA Complete and DNA Expand products offer advanced consumer genomics services with strong privacy controls and high margins.

  • The supplements business may be developed further depending on available capital.

Reconcile ProPhase valuation with carve-outs
Detail ProPhase's retained legacy liabilities
Explain Crown Medical collections management
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Prophase Labs earnings date

Logotype for Prophase Labs Inc
Q4 202527 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Prophase Labs earnings date

Logotype for Prophase Labs Inc
Q4 202527 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

ProPhase Labs, Inc. is a diversified company engaged in diagnostic testing, genomics, and consumer health products. Its diagnostic services division operates CLIA-certified labs, offering testing solutions for various health conditions, including infectious diseases. The company also focuses on genomics through its subsidiary, which provides genetic testing and research services aimed at improving personalized healthcare. Additionally, ProPhase Labs develops, markets, and distributes a range of over-the-counter consumer health products, primarily focused on immune support and respiratory health. The company is headquartered in Garden City, New York, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage